Among WHO subtypes, the frequency of low BCL3 expression in AML patients with t(8;21) was the highest (23/27, P = 0.0047), and in AML patients without chromosomal abnormalities was the lowest (4/46, P = 0.006). The gene discussed is BCL3; the disease is acute myeloid leukemia.